Stada’s new ownership is happy with holding
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Stada Arzneimittel’s controlling shareholders, Bain Capital and Cinven, are not fixated on acquiring all of the German firm’s share capital, according to Cinven partner Christopher Anderson.